BCL-2 - B-cell CLL/lymphoma 2 protein Gene
Also Known as Bcl2
Species: Oryctolagus cuniculus
Gene Type: protein coding
Gene ID: 100009447
BCL-2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| DQ529234.1 | ABF71071.1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15531 | Venetoclax | Inhibitor | 99.95% | Yes |
| HY-10201 | Sorafenib | Inhibitor | 99.85% | Yes |
| HY-B1135 | Benzbromarone | 99.91% | Yes | |
| HY-10201A | Sorafenib tosylate | Inhibitor | 99.98% | Yes |
| HY-B1357 | Digitoxin | 99.22% | Yes | |
| HY-B0402 | Amantadine | Modulator | 99.90% | Unkown |
| HY-13407 | Gossypol | Antagonist | 99.67% | Yes |
| HY-B0402A | Amantadine hydrochloride | Modulator | 98.0% | Yes |
| HY-17510 | Gossypol (acetic acid) | Inhibitor | 99.75% | Yes |
| HY-B0621 | Triclabendazole | 99.36% | Yes | |
| HY-B0402B | Amantadine sulfate | Modulator | / | Unkown |
Clinical Phase
Bioactive Molecules
(13)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-10087 | Navitoclax | Inhibitor | 99.97% | Phase 3 |
| HY-10969 | Obatoclax Mesylate | Inhibitor | 99.85% | Phase 3 |
| HY-10969A | Obatoclax | Inhibitor | ≥99.0% | Phase 3 |
| HY-129179 | Lisaftoclax | Inhibitor | 99.78% | Phase 2 |
| HY-147081A | AS 1411 sodium | Inhibitor | 99.52% | Phase 2 |
| HY-15464 | (R)-(-)-Gossypol | Inhibitor | 99.37% | Phase 2 |
| HY-15464D | (S)-Gossypol (acetic acid) | Inhibitor | 98.46% | Phase 2 |
| HY-15464A | (R)-(-)-Gossypol acetic acid | Inhibitor | 98.93% | Phase 2 |
| HY-18006 | NKP608 | Inhibitor | 99.88% | Phase 2 |
| HY-168739 | Topoisomerase I inhibitor 17 | Activator | / | Phase 2 |
| HY-117288 | S55746 | Inhibitor | 99.91% | Phase 1 |
| HY-117288A | S55746 hydrochloride | Inhibitor | 98.83% | Phase 1 |
| HY-165550 | Sphingosine | Inhibitor | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P991883 | Metuzumab | Modulator | / | Phase 4 |
| HY-P99244 | Fezakinumab | Modulator | 99.9% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(235)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-107202 | Polyinosinic-polycytidylic acid | 99.40% | Unkown | |
| HY-50907 | ABT-737 | Inhibitor | 99.64% | Unkown |
| HY-N0171A | Beta-Sitosterol (purity>98%) | 99.74% | Unkown | |
| HY-19741 | A-1331852 | Inhibitor | 99.93% | Unkown |
| HY-19725 | A-1155463 | Inhibitor | 99.60% | Unkown |
| HY-100006 | MRT68921 | Inhibitor | 98.09% | Unkown |
| HY-N0087 | Gambogic Acid | Inhibitor | 98.34% | Unkown |
| HY-107202A | Poly (I:C):Kanamycin (1:1) | 48.6% | Unkown | |
| HY-W250111 | Carboxymethyl chitosan | Activator | 90% | Unkown |
| HY-N0361 | Dihydrocapsaicin | Modulator | 99.93% | Unkown |
| HY-100006A | MRT68921 dihydrochloride | Inhibitor | 99.67% | Unkown |
| HY-N0674 | Dehydrocorydaline | Modulator | 99.77% | Unkown |
| HY-18628 | UMI-77 | Inhibitor | 99.66% | Unkown |
| HY-112416 | AZD4320 | Inhibitor | 99.66% | Unkown |
| HY-103243 | TCPOBOP | Inhibitor | 99.70% | Unkown |
| HY-B1971 | Deltamethrin | 99.93% | Unkown | |
| HY-147081 | AS 1411 | Inhibitor | 99.52% | Unkown |
| HY-W250116 | Co(III) protoporphyrin IX chloride | Inducer | ≥95.0% | Unkown |
| HY-W250122 | Glutamic acid sodium salt | Activator | 99.92% | Unkown |
| HY-N0213 | Peiminine | 99.89% | Unkown | |
| HY-12468 | A-1210477 | Inhibitor | 99.86% | Unkown |
| HY-155956 | GM-90257 | Inhibitor | 99.90% | Unkown |
| HY-N3584 | Paris saponin VII | Inhibitor | 99.84% | Unkown |
| HY-N0826 | Corynoline | Modulator | 98.84% | Unkown |
| HY-N6626 | Pyraclostrobin | 99.91% | Unkown | |
| HY-159059 | Ganoderma Lucidum/Reishi Extract | Inhibitor | 41.20% | Unkown |
| HY-125876 | PROTAC Bcl2 degrader-1 | Inhibitor | 99.80% | Unkown |
| HY-126437 | Poly-L-lysine hydrobromide (MW 30000-70000) | Inhibitor | / | Unkown |
| HY-125877 | PROTAC Mcl1 degrader-1 | Inhibitor | 98.13% | Unkown |
| HY-101259 | BMS-195614 | 99.5% | Unkown | |
| HY-W082785A | L6H21 | Modulator | 99.19% | Unkown |
| HY-12020 | TW-37 | Inhibitor | 99.50% | Unkown |
| HY-P2970 | Stem bromelain | Modulator | / | Unkown |
| HY-N2067 | Vanillyl alcohol | 99.68% | Unkown | |
| HY-N6005 | Methyl caffeate | Modulator | 99.89% | Unkown |
| HY-15191 | Sabutoclax | Inhibitor | 99.80% | Unkown |
| HY-N3009 | Secoxyloganin | Inhibitor | 99.33% | Unkown |
| HY-N6082 | Rhein 8-O-β-D-Glucopyranoside | 99.81% | Unkown | |
| HY-N0699 | Daphnoretin | Inhibitor | 99.83% | Unkown |
| HY-100383 | BH3I-1 | Inhibitor | 98.0% | Unkown |
| HY-101310 | SYM 2081 | Activator | 98.0% | Unkown |
| HY-N0566 | 23-Hydroxybetulinic acid | 99.44% | Unkown | |
| HY-129700 | MCL-1/BCL-2-IN-2 | Inhibitor | 99.05% | Unkown |
| HY-N3031 | Grosvenorine | 99.64% | Unkown | |
| HY-12011 | HA14-1 | Inhibitor | 98.0% | Unkown |
| HY-N1983 | Caudatin | 99.95% | Unkown | |
| HY-120882 | BM-1197 | Inhibitor | 99.48% | Unkown |
| HY-N0307 | Ciwujianoside B | Inhibitor | 99.68% | Unkown |
| HY-129681 | MCL-1/BCL-2-IN-1 | Inhibitor | 98.65% | Unkown |
| HY-NP192 | Sericin | Inhibitor | 0% | Unkown |
| HY-N2135 | Puerarin 6''-O-Xyloside | 99.81% | Unkown | |
| HY-16014 | A-385358 | Inhibitor | 95.10% | Unkown |
| HY-N0911 | Rehmannioside A | Modulator | 99.95% | Unkown |
| HY-179528 | DIM-3,5-Cl2 | Inhibitor | 99.18% | Unkown |
| HY-16942 | Damulin B | Inhibitor | ≥95.0% | Unkown |
| HY-W674241 | 4-Ethylphenyl sulfate | / | Unkown | |
| HY-N0853A | Alisol A 24-acetate | Inhibitor | 98.0% | Unkown |
| HY-16967 | MM41 | Inhibitor | 98.89% | Unkown |
| HY-132307 | Mcl-1 inhibitor 6 | Inhibitor | 98.77% | Unkown |
| HY-N3001 | Isolinderalactone | Inhibitor | 98.79% | Unkown |
| HY-101083 | BDA-366 | Antagonist | 98.42% | Unkown |
| HY-147929 | Apoptotic agent-3 | Activator | 98.19% | Unkown |
| HY-167881 | MLS-0053105 | Inhibitor | 98.89% | Unkown |
| HY-147785 | Pim-1 kinase inhibitor 2 | Modulator | 99.91% | Unkown |
| HY-N1423B | Glycocholic acid hydrate | Modulator | 99.85% | Unkown |
| HY-N0320 | Salvianolic acid D | Modulator | 95.15% | Unkown |
| HY-N1157 | Thevetiaflavone | Modulator | 99.83% | Unkown |
| HY-N7905 | Myricetin 3'-glucoside | Inhibitor | 99.98% | Unkown |
| HY-147187 | MNK8 | Inhibitor | 99.76% | Unkown |
| HY-N0882 | Desacetylcinobufotalin | Modulator | 99.41% | Unkown |
| HY-119979 | Cardanol monoene | 98.02% | Unkown | |
| HY-170820 | XYD049 | Inhibitor | 99.46% | Unkown |
| HY-P11706 | MS1 peptide | / | Unkown | |
| HY-111837 | BI1071 | / | Unkown | |
| HY-N17612 | Haplophytin-A | Inhibitor | / | Unkown |
| HY-N4308 | Hexamethylquercetagetin | 98.0% | Unkown | |
| HY-10087A1 | Navitoclax dihydrochloride | Inhibitor | / | Unkown |
| HY-175342 | FCN-338 | Inhibitor | 99.33% | Unkown |
| HY-19551 | Apogossypolone | Inhibitor | 98.58% | Unkown |
| HY-N6690 | Destruxin B | Activator | 99.86% | Unkown |
| HY-13408 | (+)-Apogossypol | Inhibitor | / | Unkown |
| HY-174873 | AF151 | Inhibitor | 98.87% | Unkown |
| HY-108164 | Aspidin BB | Modulator | 98.02% | Unkown |
| HY-149086 | BPA-B9 | Inhibitor | 98.50% | Unkown |
| HY-161659 | Apoptosis inducer 19 | Modulator | 98.31% | Unkown |
| HY-N9802 | n-Butyl-β-D-fructofuranoside | Activator | 97.0% | Unkown |
| HY-154860 | PTD10 | 97.38% | Unkown | |
| HY-N10144 | Shinpterocarpin | / | Unkown | |
| HY-N16483 | Procyanidin B2-3'-O-gallate | Inhibitor | / | Unkown |
| HY-131247 | Bcl-2-IN-2 | Inhibitor | / | Unkown |
| HY-18106 | BM 957 | Inhibitor | / | Unkown |
| HY-184107 | Bcl-2-IN-25 | Inhibitor | / | Unkown |
| HY-181837 | IKKβ-IN-7 | Modulator | / | Unkown |
| HY-179155 | PI3K/mTOR-IN-19 | Inhibitor | / | Unkown |
| HY-181015 | α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu | Modulator | / | Unkown |
| HY-N10313 | Dehydrobruceine B | Modulator | / | Unkown |
| HY-146105 | Anticancer agent 65 | Modulator | / | Unkown |
| HY-178446 | METTL3-IN-11 | Inhibitor | / | Unkown |
| HY-181769 | Anticancer agent 306 | Modulator | / | Unkown |
| HY-N17440 | 2-Methoxyjuglone | Modulator | / | Unkown |
| HY-180196 | EGFR-IN-187 | / | Unkown | |
| HY-149517 | EGFR/BRAFV600E-IN-2 | Activator | / | Unkown |
| HY-144791 | Bcl-2-IN-6 | Modulator | / | Unkown |
| HY-182937 | FLC-8 | Modulator | / | Unkown |
| HY-181717 | TKL002 | Inhibitor | / | Unkown |
| HY-181477 | ERK5-IN-7 | Modulator | / | Unkown |
| HY-183069 | FKL-137 | Modulator | / | Unkown |
| HY-184250 | FGFR-IN-28 | Modulator | / | Unkown |
| HY-171656 | G721-0282 | Inhibitor | 99.96% | Unkown |
| HY-100006B | MRT68921 hydrochloride | Inhibitor | / | Unkown |
| HY-181505 | BRD4-IN-12 | Degrader | / | Unkown |
| HY-176219 | Bcl-2-IN-23 | Inhibitor | / | Unkown |
| HY-151428 | Antitumor agent-78 | Inhibitor | / | Unkown |
| HY-175227 | STAT3/NF-κB-IN-1 | Inhibitor | / | Unkown |
| HY-174469 | PROTAC PI3K/110β degrader-2 | Inhibitor | / | Unkown |
| HY-P3148 | Astin B | Modulator | 95.0% | Unkown |
| HY-116267 | MHY219 | / | Unkown | |
| HY-153953 | Bcl-2-IN-11 | Inhibitor | / | Unkown |
| HY-175021 | HDAC-IN-91 | Inhibitor | / | Unkown |
| HY-179520 | XSJ151 | Modulator | / | Unkown |
| HY-144431 | Bcl-2/Mcl-1-IN-3 | Inhibitor | / | Unkown |
| HY-175588 | EGFR-IN-170 | / | Unkown | |
| HY-13846 | BM-1074 | Inhibitor | / | Unkown |
| HY-172394 | ZSNI-21 | Modulator | / | Unkown |
| HY-159513 | Bcl-2/Mcl-1-IN-4 | Inhibitor | / | Unkown |
| HY-179022 | CAIX/CDK-2-IN-1 | Inhibitor | / | Unkown |
| HY-184443 | Bcl-2-IN-26 | Inhibitor | / | Unkown |
| HY-182031 | JS04 | Activator | / | Unkown |
| HY-149009 | Bcl-2-IN-9 | Inhibitor | / | Unkown |
| HY-180823 | Topoisomerase II/EGFR-IN-2 | Inhibitor | / | Unkown |
| HY-184116 | A2AR/EGFR-IN-1 | Modulator | / | Unkown |
| HY-172886 | PI3K-IN-58 | Modulator | / | Unkown |
| HY-181060 | Apoptosis inducer 56 | Modulator | / | Unkown |
| HY-135275 | BCL-XL-IN-4 | Inhibitor | / | Unkown |
| HY-169431 | VEGFR-2/AKT-IN-2 | Inhibitor | / | Unkown |
| HY-138071 | 8α-Tigloyloxyhirsutinolide 13-O-acetate | Inhibitor | 95.0% | Unkown |
| HY-181659 | EGFR-IN-201 | Inhibitor | / | Unkown |
| HY-181098 | FKA-9i | Inhibitor | / | Unkown |
| HY-170912 | Topo I/II-IN-2 | / | Unkown | |
| HY-182706 | NSC 373981 | Inhibitor | / | Unkown |
| HY-107272 | Chuanbeinone | / | Unkown | |
| HY-N13338 | Avicin D | Inhibitor | / | Unkown |
| HY-182016 | PROTAC ATR degrader-3 | / | Unkown | |
| HY-143235 | BRD4 Inhibitor-15 | Modulator | / | Unkown |
| HY-180242 | EGFR/CDK2-IN-5 | Modulator | / | Unkown |
| HY-183327 | PI3K/mTOR-IN-22 | / | Unkown | |
| HY-180245 | STAT3-IN-51 | Inhibitor | / | Unkown |
| HY-183312 | Antitumor agent-217 | Inhibitor | / | Unkown |
| HY-146253 | CDK1/2/4-IN-1 | Activator | / | Unkown |
| HY-180274 | JAK1/2-IN-3 | / | Unkown | |
| HY-144430 | Bcl-2/Mcl-1-IN-1 | Inhibitor | / | Unkown |
| HY-147928 | Apoptotic agent-2 | Activator | / | Unkown |
| HY-170946 | WR-S-462 | Inhibitor | / | Unkown |
| HY-178942 | EGFR/VEGFR2-IN-9 | Inhibitor | / | Unkown |
| HY-174338 | GPER/Bcl-2-IN-1 | Inhibitor | / | Unkown |
| HY-N6799 | Neosolaniol | Activator | 99.72% | Unkown |
| HY-181061 | COX/5-LO-IN-2 | Modulator | / | Unkown |
| HY-176288 | eIF4E/eIF4G PPI-IN-1 | Inhibitor | / | Unkown |
| HY-175815 | Apoptosis inducer 44 | Inhibitor | / | Unkown |
| HY-181746 | Bcl-2/Mcl-1-IN-5 | Inhibitor | / | Unkown |
| HY-183791A | Ferroptosis/apoptosis inducer-5 | Modulator | / | Unkown |
| HY-147514 | Anticancer agent 64 | Modulator | / | Unkown |
| HY-180154 | EGFR/BRAFV600E-IN-6 | / | Unkown | |
| HY-177208 | BW-AQ-113 | / | Unkown | |
| HY-143872 | Bcl-2-IN-4 | Inhibitor | / | Unkown |
| HY-183772 | TBC1D2-IN-1 | Modulator | / | Unkown |
| HY-178099 | Apoptosis inducer 45 | Inhibitor | / | Unkown |
| HY-174403 | c-MYC/BCL2 ligand 1 iodide | Ligand | / | Unkown |
| HY-P2012 | TRP-601 | / | Unkown | |
| HY-W717425 | SC-60 | Inhibitor | / | Unkown |
| HY-151429 | Antitumor agent-77 | Inhibitor | / | Unkown |
| HY-184145 | AKT1-IN-13 | Inhibitor | / | Unkown |
| HY-167237 | Calactin | Modulator | / | Unkown |
| HY-149978 | LSD1-IN-26 | Inhibitor | / | Unkown |
| HY-175010 | STAT3-IN-44 | Inhibitor | / | Unkown |
| HY-181174 | Antioxidant agent-22 | / | Unkown | |
| HY-181506 | TYMJ-01 | Inhibitor | / | Unkown |
| HY-183355 | KRAS G12D-IN-37 | / | Unkown | |
| HY-161415 | BCL-xL/BCL-2 ligand 1 | / | Unkown | |
| HY-175175 | MAPK-IN-5 | Inhibitor | / | Unkown |
| HY-184302 | Apoptosis inducer 62 | Inhibitor | / | Unkown |
| HY-174419 | TFSeB | Activator | / | Unkown |
| HY-163435 | Anticancer agent 201 | Inhibitor | / | Unkown |
| HY-155251 | anti-TNBC agent-3 | / | Unkown | |
| HY-158677 | BcI-2/BcI-xI ligand 1 | / | Unkown | |
| HY-175848 | NSC 850745 | Inhibitor | / | Unkown |
| HY-184448 | CIB-Q22 | Modulator | / | Unkown |
| HY-175332 | Apoptosis inducer 43 | Inhibitor | / | Unkown |
| HY-181019 | iMPZ-8 | / | Unkown | |
| HY-N1326 | Santamarine | 98.85% | Unkown | |
| HY-179614 | PARP1-IN-50 | / | Unkown | |
| HY-181599 | XAN-5 | / | Unkown | |
| HY-176740 | PROTAC Bcl-xL degrader-4 | Degrader | / | Unkown |
| HY-180324 | Candidone | Inhibitor | / | Unkown |
| HY-168623 | EGFR-IN-134 | Inhibitor | / | Unkown |
| HY-181248 | BChE-IN-49 | Inhibitor | / | Unkown |
| HY-180190 | Tubulin polymerization-IN-85 | / | Unkown | |
| HY-P11374 | Bid BH3-Gly-r8 | Ligand | / | Unkown |
| HY-178142 | Multi-kinase-IN-7 | Inhibitor | / | Unkown |
| HY-185559 | Mito-fisetin mF7 | / | Unkown | |
| HY-127130 | Spicamycin | Inhibitor | / | Unkown |
| HY-N17816 | Tambulin | Inhibitor | / | Unkown |
| HY-143873 | Bcl-2-IN-5 | Inhibitor | / | Unkown |
| HY-180820 | Dimethyl bisphenolate | / | Unkown | |
| HY-181795 | CSN5-IN-3 | Inhibitor | / | Unkown |
| HY-183771 | CDK4/6-IN-28 | Inhibitor | / | Unkown |
| HY-181018 | Topo I/DDX5-IN-1 | Inhibitor | / | Unkown |
| HY-183369 | VEGFR/PD-L1-IN-1 | Activator | / | Unkown |
| HY-122275 | A-371191 | Antagonist | / | Unkown |
| HY-178910 | Mcl-1-IN-20 | Inhibitor | / | Unkown |
| HY-182760 | MN33-63 | Inhibitor | / | Unkown |
| HY-147504 | Anticancer agent 63 | Modulator | / | Unkown |
| HY-144792 | Bcl-2-IN-7 | Modulator | / | Unkown |
| HY-179480 | G-quadruplex ligand 4 | Inhibitor | / | Unkown |
| HY-175037 | DNH28 | Inhibitor | / | Unkown |
| HY-144428 | Bcl-2/Mcl-1-IN-2 | Inhibitor | / | Unkown |
| HY-175771 | STAT3-IN-46 | Inhibitor | / | Unkown |
| HY-174992 | Apoptosis inducer 39 | / | Unkown | |
| HY-123244 | YC137 | Antagonist | / | Unkown |
| HY-162360 | EGFR-IN-109 | Inhibitor | / | Unkown |
| HY-181673 | ICD inducer-2 | / | Unkown | |
| HY-117652 | Lobetyol | Modulator | / | Unkown |
| HY-170929 | EMT inhibitor-3 | / | Unkown | |
| HY-180618 | p53 DUBTAC modulator-1 | Inhibitor | / | Unkown |
| HY-178104 | HDAC-IN-93 | Inhibitor | / | Unkown |
| HY-131405 | β-Eleostearic acid | Inhibitor | / | Unkown |
| HY-174855 | PI3K/mTOR-IN-17 | Inhibitor | / | Unkown |
| HY-182360 | Cytisine-platinum(IV) prodrug-1 | / | Unkown | |
| HY-N16929 | Gymnoside II | Activator | / | Unkown |
| HY-182759 | MN33-47 | Inhibitor | / | Unkown |
| HY-181030 | BDE30671203 | Inhibitor | / | Unkown |
| HY-136714 | Bcl-2-IN-3 | Inhibitor | / | Unkown |
| HY-116532 | YCW-E11 | Inhibitor | / | Unkown |
| HY-N15466 | Longan cerebroside II | / | Unkown | |
| HY-115529 | (-)BI97D6 | / | Unkown |